Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (261-270 of 4,097) with videos related to

Pageof 410
Sort By:
Cancer Cell|July 10, 2019
Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological MalignanciesNikolas G Balanis, Katherine M Sheu, Favour N Esedebe, et al.
Cancer Cell|July 10, 2019
M-TAP Dance: Targeting PRMT1 and PRMT5 Family Members to Push Cancer Cells Over the EdgeNivine Srour, Sofiane Y Mersaoui, Stéphane Richard
Cancer Cell|July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
Cancer Cell|February 24, 2022
Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipientsMuhammad Bilal Abid, Micah Rubin, Nathan Ledeboer, et al.
Cancer Cell|February 15, 2022
Lactobacillus reuteri-an old acquaintance takes on a new task in colorectal tumor surveillanceChristina Watschinger, Alexander R Moschen
Cancer Cell|February 5, 2022
Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapyAssia Asrir, Claire Tardiveau, Juliette Coudert, et al.
Cancer Cell|February 5, 2022
Metastasis and organotropism: A look through the lens of large-scale clinical sequencing dataAlexander Coulton, Samra Turajlic
Cancer Cell|February 12, 2022
Leveraging self-assembled nanobiomaterials for improved cancer immunotherapyMichael P Vincent, Justin O Navidzadeh, Sharan Bobbala, et al.
Cancer Cell|February 17, 2022
Stem-cell-like T cells have a specific entry gate to the tumorWerner Held, Sanjiv A Luther, Tatiana V Petrova
Cancer Cell|March 15, 2022
Time to raise the bar: Transition rate of phase 1 programs on anticancer drugsShen Zhao, Dong Wang, Hongyun Zhao, et al.
Pageof 410

Showing results (261-270 of 4,097) with videos related to

Sort By:
Pageof 410
Cancer Cell|July 10, 2019
Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological MalignanciesNikolas G Balanis, Katherine M Sheu, Favour N Esedebe, et al.
Cancer Cell|July 10, 2019
M-TAP Dance: Targeting PRMT1 and PRMT5 Family Members to Push Cancer Cells Over the EdgeNivine Srour, Sofiane Y Mersaoui, Stéphane Richard
Cancer Cell|July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
Cancer Cell|February 24, 2022
Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipientsMuhammad Bilal Abid, Micah Rubin, Nathan Ledeboer, et al.
Cancer Cell|February 15, 2022
Lactobacillus reuteri-an old acquaintance takes on a new task in colorectal tumor surveillanceChristina Watschinger, Alexander R Moschen
Cancer Cell|February 5, 2022
Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapyAssia Asrir, Claire Tardiveau, Juliette Coudert, et al.
Cancer Cell|February 5, 2022
Metastasis and organotropism: A look through the lens of large-scale clinical sequencing dataAlexander Coulton, Samra Turajlic
Cancer Cell|February 12, 2022
Leveraging self-assembled nanobiomaterials for improved cancer immunotherapyMichael P Vincent, Justin O Navidzadeh, Sharan Bobbala, et al.
Cancer Cell|February 17, 2022
Stem-cell-like T cells have a specific entry gate to the tumorWerner Held, Sanjiv A Luther, Tatiana V Petrova
Cancer Cell|March 15, 2022
Time to raise the bar: Transition rate of phase 1 programs on anticancer drugsShen Zhao, Dong Wang, Hongyun Zhao, et al.
Pageof 410